Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The former Playboy model, 39, started injecting the drug after being body-shamed by internet trolls earlier this year.

Diabetes mellitus is most commonly known as diabetes, which is a disease that affects how the body uses glucose or blood ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...